Oral Vaccine Development for Schistosomiasis Using Salmonella
Author Information
Author(s): Chen Guo, Dai Yang, Chen Jianxiang, Wang Xiaoting, Tang Bo, Zhu Yinchang, Hua Zichun
Primary Institution: Nanjing University, People's Republic of China
Hypothesis
Can an oral vaccine using Salmonella typhimurium effectively protect against Schistosoma japonicum infection in mice?
Conclusion
The study found that an oral vaccine using Salmonella typhimurium effectively protects against Schistosoma japonicum infection in mice.
Supporting Evidence
- The vaccine induced a Th1-specific immune response in mice.
- Significant reductions in worm and egg burdens were observed in vaccinated mice.
- The oral delivery method is safe and effective for vaccine development.
Takeaway
Researchers created a vaccine using a type of bacteria that can be taken by mouth, which helps protect mice from a harmful parasite.
Methodology
The study used an attenuated Salmonella typhimurium strain to express and deliver a Schistosoma japonicum antigen and tested its efficacy in mice.
Limitations
The study primarily focused on a mouse model, which may not fully represent human responses.
Participant Demographics
Female BALB/c mice, aged 6-8 weeks.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website